Skip to main content

BGI, Utrecht Ink Partnership

NEW YORK (GenomeWeb News) – BGI has signed an agreement with Utrecht University and University Medical Center Utrecht to establish a genomics research partnership in the Netherlands under which BGI will provide its next-generation sequencing and bioinformatics platforms, Utrecht Life Sciences said.

The partnership, which will focus on joint large-scale genome sequencing and functional genomics, will provide Utrecht researchers access to BGI's resources and will provide BGI with access to the research resources at the Utrecht institutes.

Financial and other details about the partnership were not released.

Today's announcement follows a similar deal BGI and the University of California, Davis announced in June.

Utrecht Life Sciences is an alliance between partners in education, research, and entrepreneurs in the region that seeks to initiate networks involved in research in basic, translational, and clinical research areas.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.